An immunohistochemical study of cyclin D1 protein expression in laryngeal squamous cell carcinoma

Acta Oto-Laryngologica

Volumn 127, Issue 7, 2007, Pages 760-769

  Morshed, Kamal ^a,b   Skomra, Danuta ^a   Korobowicz, Elzbieta ^a   Szymański, Marcin ^a   Polz Dacewicz, Małgorzata ^a   Gołabek, Wiesław ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Department of Otolaryngology Head and Neck Surgery ^*  (Poland)

Author keywords

Cyclin D1 protein expression; Immunohistochemical staining; Laryngeal cancer; Survival rates

Indexed keywords

CYCLIN D1;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYCLIN D1; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL MUCOSA; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34250633534     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480601001957     Document Type: Article

References (25)

1. Maier H, Dietz A, Gewelka U, Heller WD, Weidauer H. Tobacco and alcohol and the risk of head and neck cancer. Clin Investig 1992;70:320-7.
2. Morshed K, Korobowicz E, Szymanski M, Skomra D, Golabek W. Immunohistochemical demonstration of multiple HPV types in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2005;262:917-20.
3. Cattaruzza MS, Maisonneuve P, Boyle P. Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol 1996;32B:293-305.
4. Robin PE, Olofsson J. Tumours of the larynx. In: Scott-Brown's otolaryngology, vol. 5, 5th edn. London: Butterworth; 1987.
5. Weinstein IB. The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment. Twenty-seventh G. H.A. Clowes memorial award lecture. Cancer Res 1988;48:4135-43.
6. Bellacosa A, Almadori G, Cavallo S, Cadoni G, Galli J, Ferrandina G, et al. Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res 1996;2:175-80.
7. Shin DM, Hittelman WN, Hong WK. Biomarkers in upper aerodigestive tract tumorigenesis: a review. Cancer Epidemiol Biomarkers Prev 1994;3:697-709.
8. Kyomoto R, Kumazawa H, Toda Y, Sakaida N, Okamura A, Iwanaga M, et al. Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer 1997;74:576-81.
9. Muller D, Millon R, Lidereau R, Engelmann A, Bronner G, Flesch H, et al. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur J Cancer B Oral Oncol 1994;30B:113-20.
10. Michalides RJ, van Veelen NM, Kristel PM, Hart AA, Loftus BM, Hilgers FJ, et al. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1997;123:497-502.
11. Mielcarek-Kuchta D, Olofsson J, Golusinski W. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma. Eur Arch Otorhinolaryngol 2003;260:549-54.
12. Sewing A, Burger C, Brusselbach S, Schalk C, Lucibello FC, Muller R. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J Cell Sci 1993;104:545-54.
13. Peters G. The D-type cyclins and their role in tumorigenesis. J Cell Sci 1994;(Suppl 18):89-96.
14. Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ. Identification and cloning of two overexpressed genes, U21B31/PRA D1 and EMS1, within the amplified chromosomal 11q13 region in human carcinomas. Oncogene 1992;7:355-61.
15. Vielba R, Bilbao J, Ispizua A, Zabalza I, Alfaro J, Rezola R, et al. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 2003;113:167-72.
16. Krecicki T, Smigiel R, Fraczek M, Kowalczyk M, Sasiadek MM. Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue. J Laryngol Otol 2004;118:676-80.
17. Segas JV, Lazaris AC, Nikolopoulos TP, Kavantzas NG, Lendari IE, Tzagkaroulakis AM, et al. Cyclin D1 protein tissue detection in laryngeal cancer. ORL J Otorhinolaryngol Relat Spec 2005;67:319-25.
18. van Diest PJ, Michalides RJ, Jannink L, van der Valk P, Peterse HL, de Jong JS, et al. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am J Pathol 1997;150:705-11.
19. Pignataro L, Pruneri G, Carboni N, Capaccio P, Cesana BM, Neri A, et al. Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. Clin Oncol 1998;16:3069-77.
20. Pera E, Moreno A, Galindo L. Prognostic factors in laryngeal carcinoma: a multifactorial study of 4416 cases. Cancer 1986;58:928-34.
21. Truelson JM, Fisher SG, Beals TE, McClatchey KD, Wolf GT. DNA content and histological growth pattern correlate with advanced squamous cell carcinoma of the larynx. Cancer 1992;70:56-72.
22. Ispizua A, Baroja A, de la Hoz C. Correlation of DNA content of laryngeal epithelial lesions to degree of malignancy. J Clin Oncol 1994;12:1600-6.
23. Fracchiolla NS, Pignataro L, Capaccio P, Trecca D, Boletni A, Ottaviani A, et al. Multiple genetic lesions in laryngeal squamous cell carcinomas. Cancer 1995;75:1292-301.
24. Capaccio P, Pruneri G, Carboni N, Pagliari AV, Buffa R, Neri A, et al. Cyclin D1 protein expression is related to clinical progression in laryngeal squamous cell carcinomas. J Laryngol Otol 1997;111:622-6.
25. Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, et al. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. J Exp Clin Cancer Res 2004;3:277-83.